Digestives & Intestinal Remedies - New Zealand

New Zealand

Highlights

In New Zealand, the revenue generated in the Digestives & Intestinal Remedies market market is estimated to be US$16.98m in 2024.
It is projected that the market will experience an annual growth rate of 3.50% (CAGR 2024-2029).
When compared to other countries worldwide, China leads the market with a revenue of US$4.41bn in 2024.
Taking into account the total population, the per person revenue in New Zealand amounts to US$3.22 in 2024.
New Zealand's increasing focus on natural and herbal remedies is driving the demand for digestive and intestinal remedies in the OTC Pharmaceuticals market.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Digestives & Intestinal Remedies market in New Zealand has experienced steady growth in recent years, driven by changing customer preferences, emerging trends, and local special circumstances. Customer preferences in the Digestives & Intestinal Remedies market have shifted towards natural and herbal remedies, as consumers become more health-conscious and seek alternative treatments. This trend is in line with the global market, where there is a growing demand for natural and organic products. Customers are increasingly looking for digestive remedies that are free from artificial ingredients and chemicals, and that promote overall gut health. This shift in preferences has led to the introduction of a wide range of natural digestive remedies in the New Zealand market, including herbal teas, probiotics, and dietary supplements.One of the key trends in the Digestives & Intestinal Remedies market in New Zealand is the increasing popularity of probiotics. Probiotics are live bacteria and yeasts that are beneficial for the digestive system. They help restore the natural balance of bacteria in the gut and improve digestion. The demand for probiotics has been driven by the growing awareness of the importance of gut health and the role of beneficial bacteria in maintaining overall well-being. This trend is in line with the global market, where probiotics have gained significant popularity in recent years.Another trend in the market is the rising demand for digestive remedies for specific conditions, such as irritable bowel syndrome (IBS) and acid reflux. These conditions affect a large number of people in New Zealand and globally, and there is a growing need for effective and targeted treatments. As a result, there has been an increase in the availability of specialized digestive remedies that are formulated to address specific digestive issues. This trend reflects the growing understanding of the complexity of digestive disorders and the need for tailored solutions.In addition to changing customer preferences and emerging trends, there are also local special circumstances that have influenced the development of the Digestives & Intestinal Remedies market in New Zealand. One of these special circumstances is the country's high prevalence of gastrointestinal disorders. New Zealand has one of the highest rates of gastrointestinal diseases in the world, which has created a significant demand for digestive remedies. The local market has responded to this demand by offering a wide range of products and treatments for various digestive conditions.Underlying macroeconomic factors have also played a role in the growth of the Digestives & Intestinal Remedies market in New Zealand. The country's strong economy and high disposable income levels have contributed to increased consumer spending on healthcare and wellness products. As people become more health-conscious, they are willing to invest in products that promote digestive health and overall well-being. This favorable economic environment has created a conducive market for the growth of the Digestives & Intestinal Remedies industry in New Zealand.In conclusion, the Digestives & Intestinal Remedies market in New Zealand is developing in response to changing customer preferences, emerging trends, local special circumstances, and underlying macroeconomic factors. The shift towards natural and herbal remedies, the increasing popularity of probiotics, and the demand for specialized digestive remedies are driving the growth of the market. The high prevalence of gastrointestinal disorders in the country and the favorable economic environment also contribute to the development of the market.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.